The regulation of reactive changes around multiple sclerosis lesions by phosphorylated signal transducer and activator of transcription

Journal of Neuropathology and Experimental Neurology

Volumn 72, Issue 12, 2013, Pages 1135-1144

  Lu, Jian Qiang ^a   Power, Christopher ^a   Blevins, Gregg ^a   Giuliani, Fabrizio ^a   Wee Yong, V ^b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Astrocytes; Gliosis; Immunoreactivity; Macrophages Microglia; Multiple sclerosis; STAT3; White matter

Indexed keywords

PHOSPHORYLATED SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTE; BRAIN DAMAGE; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; INFLAMMATION; MACROPHAGE; MALE; MICROGLIA; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; WHITE MATTER;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; BRAIN; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN BASIC PROTEIN; NERVE TISSUE PROTEINS; NEUROGLIA; NEURONS; PHOSPHORYLATION; POSTMORTEM CHANGES; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; YOUNG ADULT;

EID: 84889081166     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000011     Document Type: Article

References (40)

1. Bhattacharya S, Schindler C. Regulation of Stat3 nuclear export. J Clin Invest 2003;111:553-59 (Pubitemid 36228012)
2. Liu L, McBride KM, Reich NC. STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3. Proc Natl Acad Sci U S A 2005;102:8150-55 (Pubitemid 40800058)
3. Bromberg J, Darnell JE Jr. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000;19:2468-67
4. Darnell JE Jr. STATs and gene regulation. Science 1997;277:1630-35 (Pubitemid 27446219)
5. Bild AH, Turkson J, Jove R. Cytoplasmic transport of Stat3 by receptor-mediated endocytosis. EMBO J 2002;21:3255-56
6. Takeda K, Noguchi K, Shi W, et al. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality. Proc Natl Acad Sci U S A 1997;94:3801-4 (Pubitemid 27180453)
7. Herrmann JE, Imura T, Song B, et al. STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 2008; 28:7231-43
8. Cannella B, Raine CS. Multiple sclerosis: Cytokine receptors on oligodendrocytes predict innate regulation. Ann Neurol 2004;55:46-57 (Pubitemid 38067360)
9. Sriram K, Benkovic SA, Hebert MA, et al. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine model of neurodegeneration: Key signaling pathway for astrogliosis in vivo? J Biol Chem 2004;279:19936-47 (Pubitemid 38623436)
10. Yamauchi K, Osuka K, Takayasu M, et al. Activation of JAK/STAT signalling in neurons following spinal cord injury in mice. J Neurochem 2006;96:1060-70
11. Cattaneo E, Conti L, De-Fraja C. Signalling through the JAK-STAT pathway in the developing brain. Trends Neurosci 1999;22:365-69 (Pubitemid 29339250)
12. Acarin L, González B, Castellano B. STAT3 and NFkappaB activation precedes glial reactivity in the excitotoxically injured young cortex but not in the corresponding distal thalamic nuclei. J Neuropathol Exp Neurol 2000;59:151-63 (Pubitemid 30106471)
13. Justicia C, Gabriel C, Planas AM. Activation of the JAK/STAT pathway following transient focal cerebral ischemia: Signaling through Jak1 and Stat3 in astrocytes. Glia 2000;30:253-70 (Pubitemid 30259665)
14. Xu Z, Xue T, Zhang Z, et al. Role of signal transducer and activator of transcription-3 in up-regulation of GFAP after epilepsy. Neurochem Res 2011;36:2208-15
15. Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis. Oncogene 2000;19:2474-88 (Pubitemid 30339203)
16. de la Iglesia N, Puram SV, Bonni A. STAT3 regulation of glioblastoma pathogenesis. Curr Mol Med 2009;9:580-90
17. + T helper cell differentiation and inflammatory diseases. Cytokine 2009;47:149-56
18. Yu H, Kortylewski M, Pardoll D. Crosstalk between cancer and immune cells: Role of STAT3 in the tumour microenvironment. Nat Rev Immunol 2007;7:41-51 (Pubitemid 46020826)
19. Yu H, Pardoll D, Jove R. STATs in cancer inflammation and immunity: A leading role for STAT3. Nat Rev Cancer 2009;9:798-809
20. El Kasmi KC, Holst J, Coffre M, et al. General nature of the STAT3-activated anti-inflammatory response. J Immunol 2006;177:7880-88 (Pubitemid 44846303)
21. Murray PJ. STAT3-mediated anti-inflammatory signalling. Biochem Soc Trans 2006;34:1028-31 (Pubitemid 46768982)
22. Frisullo G, Angelucci F, Caggiula M, et al. pSTAT1, pSTAT3, and T-bet expression in peripheral blood mononuclear cells from relapsing-remitting multiple sclerosis patients correlates with disease activity. J Neurosci Res 2006;84:1027-36 (Pubitemid 44521047)
23. Frisullo G, Patanella AK, Nociti V, et al. Glioblastoma in multiple sclerosis: A case report. J Neurooncol 2009;94:141-44
24. Madia F, Frisullo G, Nociti V, et al. pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 2009;14:107-17
25. Baranzini SE, Galwey NW, Wang J, et al. Pathway and network-based analysis of genome-wide association studies in multiple sclerosis. Hum Mol Genet 2009;18:2078-90
26. Jakkula E, Leppä V, Sulonen AM, et al. Genome-wide association study in a high-risk isolate for multiple sclerosis reveals associated variants in STAT3 gene. Am J Hum Genet 2010;86:285-91
27. Lill CM, Schjeide BM, Akkad DA, et al. Independent replication of STAT3 association with multiple sclerosis risk in a large German case-control sample. Neurogenetics 2012;13:83-86
28. Cénit MC, Alcina A, Márquez A, et al. STAT3 locus in inflammatory bowel disease and multiple sclerosis susceptibility. Genes Immun 2010; 11:264-68
29. + T cells prevents development of experimental autoimmune diseases. J Immunol 2008; 180:6070-76
30. Frisullo G, Mirabella M, Angelucci F, et al. The effect of disease activity on leptin, leptin receptor and suppressor of cytokine signalling-3 expression in relapsing-remitting multiple sclerosis. J Neuroimmunol 2007; 192:174-83 (Pubitemid 350214563)
31. + T cells from CIS patients favors the early conversion to clinically defined multiple sclerosis. J Neuroimmunol 2008; 205:126-34
32. Trapp BD, Peterson J, Ransohoff RM, et al. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998;338:278-85 (Pubitemid 28065253)
33. van der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: Pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000;26:2-10 (Pubitemid 30145301)
34. Lu JQ, Fan Y, Mitha AP, et al. Association of alpha-synuclein immunoreactivity with inflammatory activity in multiple sclerosis lesions. J Neuropathol Exp Neurol 2009;68:179-89
35. Noorbakhsh F, Tsutsui S, Vergnolle N, et al. Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis. J Exp Med 2006;203:425-35 (Pubitemid 43290851)
36. Choi JS, Kim SY, Cha JH, et al. Upregulation of gp130 and STAT3 activation in the rat hippocampus following transient forebrain ischemia. Glia 2003;41:237-46 (Pubitemid 36258469)
37. Shibata N, Kakita A, Takahashi H, et al. Activation of signal transducer and activator of transcription-3 in the spinal cord of sporadic amyotrophic lateral sclerosis patients. Neurodegener Dis 2009;6:118-26
38. Nobuta H, Ghiani CA, Paez PM, et al. STAT3-mediated astrogliosis protects myelin development in neonatal brain injury. Ann Neurol 2012;72:750-65
39. Zhang J, Zhang Y, Dutta DJ, et al. Proapoptotic and antiapoptotic actions of Stat1 versus Stat3 underlie neuroprotective and immunoregulatory functions of IL-11. J Immunol 2011;187:1129-41
40. + T cells accumulate in peripheral blood during NZB treatment. Mult Scler 2011;17:556-66